Clinical trial
Effects of Triiodothyronine (T3) in Ischemic Heart Failure
NCT05384847 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Triiodothyronine (T3) in Ischemic Heart Failure
- Lead sponsor
- Emory University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 2, 2022
- Completion date
- October 1, 2025
- Enrollment
- 14 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.